Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically hig... Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard. Mehr anzeigen
Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test PR Newswire NEW YORK, Nov. 20, 2024 NEW YORK, Nov. 20, 2024 /PRNewswire/...
Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum PR Newswire NEW YORK, Nov. 18, 2024 NEW YORK, Nov. 18, 2024 /PRNewswire/...
PAVmed Provides Business Update and Third Quarter 2024 Financial Results PR Newswire NEW YORK, Nov. 14, 2024 Lucid reports record quarterly EsoGuard® revenue and completes clinical evidence...
Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results PR Newswire NEW YORK, Nov. 13, 2024 EsoGuard® revenue up 20 percent sequentially Clinical evidence package for...
Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication PR Newswire NEW YORK, Nov. 7...
Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers PR Newswire NEW YORK, Nov. 5, 2024 Industry veterans from leading cancer...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0258 | -2.49082834524 | 1.0358 | 1.04 | 0.9029 | 598463 | 0.98143943 | CS |
| 4 | 0.16 | 18.8235294118 | 0.85 | 1.12 | 0.8456 | 508733 | 0.99204631 | CS |
| 12 | 0.2112 | 26.4396594892 | 0.7988 | 1.12 | 0.73 | 295676 | 0.91967317 | CS |
| 26 | 0.09 | 9.78260869565 | 0.92 | 1.12 | 0.681 | 224660 | 0.88082319 | CS |
| 52 | -0.29 | -22.3076923077 | 1.3 | 1.58 | 0.6301 | 182322 | 0.94228395 | CS |
| 156 | -8.67 | -89.5661157025 | 9.68 | 9.68 | 0.6301 | 131532 | 1.98751874 | CS |
| 260 | -11.74 | -92.0784313725 | 12.75 | 13.5 | 0.6301 | 140508 | 2.79829123 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
